Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)

NCT01020747 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Respiratory Papillomatosis

Interventions

DRUG: Avastin® (bevacizumab)
DRUG: Saline

Sponsor

Massachusetts General Hospital